116 related articles for article (PubMed ID: 9482389)
21. White cell apoptosis in platelet concentrates.
Frabetti F; Tazzari PL; Musiani D; Bontadini A; Matteini C; Roseti L; Tassi C; Viggiani M; Marini M; Conte R
Transfusion; 2000 Feb; 40(2):160-8. PubMed ID: 10685999
[TBL] [Abstract][Full Text] [Related]
22. Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates.
Weisbach V; Wanke C; Zingsem J; Zimmermann R; Eckstein R
Vox Sang; 1999; 76(2):100-6. PubMed ID: 10085526
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of leukocyte-depleted platelet concentrates obtained by in-line filtration.
Ferrer F; Rivera J; Corral J; González-Conejero R; Vicente V
Vox Sang; 2000; 78(4):235-41. PubMed ID: 10895097
[TBL] [Abstract][Full Text] [Related]
24. Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage.
Lozano M; Estebanell E; Cid J; Diaz-Ricart M; Mazzara R; Ordinas A; Escolar G
Transfusion; 1999 Sep; 39(9):951-9. PubMed ID: 10533821
[TBL] [Abstract][Full Text] [Related]
25. Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems.
Devine DV; Bradley AJ; Maurer E; Levin E; Chahal S; Serrano K; Gyongyossy-Issa MI
Transfusion; 1999 Jul; 39(7):724-34. PubMed ID: 10413280
[TBL] [Abstract][Full Text] [Related]
26. Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays.
Wadhwa M; Seghatchian MJ; Lubenko A; Contreras M; Dilger P; Bird C; Thorpe R
Br J Haematol; 1996 Apr; 93(1):225-34. PubMed ID: 8611466
[TBL] [Abstract][Full Text] [Related]
27. Low cytokine contamination in buffy coat-derived platelet concentrates without filtration.
Flegel WA; Wiesneth M; Stampe D; Koerner K
Transfusion; 1995; 35(11):917-20. PubMed ID: 8604488
[TBL] [Abstract][Full Text] [Related]
28. Transfusion of platelet concentrates from pooled buffy-coats: comparison of bedside vs. prestorage leukofiltration.
Müller-Steinhardt M; Schlenke P; Wagner T; Klüter H
Transfus Med; 2000 Mar; 10(1):59-65. PubMed ID: 10760204
[TBL] [Abstract][Full Text] [Related]
29. Platelet concentrates in platelet additive solutions generate less complement activation products during storage than platelets stored in plasma.
de Wit YES; Vlaar R; Gouwerok E; Hamzeh-Cognasse H; van Mierlo G; Bulder I; Lagerberg JWM; de Korte D; Cognasse F; Ten Brinke A; Zeerleder SS
Blood Transfus; 2023 Mar; 21(2):157-167. PubMed ID: 35302481
[TBL] [Abstract][Full Text] [Related]
30. Treatment of platelets with riboflavin and ultraviolet light mediates complement activation and suppresses monocyte interleukin-12 production in whole blood.
Loh YS; Dean MM; Johnson L; Marks DC
Vox Sang; 2015 Nov; 109(4):327-35. PubMed ID: 25975771
[TBL] [Abstract][Full Text] [Related]
31. Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions.
Muylle L; Joos M; Wouters E; De Bock R; Peetermans ME
Transfusion; 1993 Mar; 33(3):195-9. PubMed ID: 8438219
[TBL] [Abstract][Full Text] [Related]
32. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
Ali SF
Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo effects of prestorage filtration of apheresis platelets.
Sweeney JD; Holme S; Stromberg RR; Heaton WA
Transfusion; 1995 Feb; 35(2):125-30. PubMed ID: 7825207
[TBL] [Abstract][Full Text] [Related]
34. Relationship between cytokines and leukotriene B4 in sepsis.
Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):151-6. PubMed ID: 8202628
[TBL] [Abstract][Full Text] [Related]
35. Modulation of C5a-mediated effector functions of human polymorphonuclear leukocytes by tumor necrosis factor alpha and granulocyte macrophage colony-stimulating factor.
Binder R; Kress A; Kirschfink M
Exp Clin Immunogenet; 1999; 16(4):212-25. PubMed ID: 10575275
[TBL] [Abstract][Full Text] [Related]
36. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets.
Krailadsiri P; Seghatchian J
Vox Sang; 2000; 78(3):171-5. PubMed ID: 10838518
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo evaluation of cotton wool filtration of platelet concentrates obtained by automated and manual apheresis.
Holme S; Snyder E; Heaton A; Keegan T; Napychank P
Transfusion; 1992 May; 32(4):328-33. PubMed ID: 1585437
[TBL] [Abstract][Full Text] [Related]
38. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates.
Muylle L; Peetermans ME
Vox Sang; 1994; 66(1):14-7. PubMed ID: 8146977
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
[TBL] [Abstract][Full Text] [Related]
40. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
